Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Lee's Pharmaceutical Holdings Ltd

+ Add to Watchlist

950:HK

13.700 HKD 1.300 8.67%

As of 04:01:05 ET on 05/29/2015.

Snapshot for Lee's Pharmaceutical Holdings Ltd (950)

Open: 14.260 Day's Range: 12.900 - 14.260 Volume: 1,689,500
Previous Close: 15.000 52wk Range: 8.800 - 15.400 1-Yr Rtn: +53.65%

Stock Chart for 950

No chart data available.
  • 950:HK 13.700
  • 1D
  • 1M
  • 1Y
15.000
Interactive 950 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 950

Current P/E Ratio (ttm) 39.0947
Estimated P/E(12/2015) 31.1364
Relative P/E vs. HSI 3.6780
Earnings Per Share (HKD) (ttm) 0.3504
Est. EPS (HKD) (12/2015) 0.4400
Est. PEG Ratio -
Market Cap (M HKD) 8,007.46
Shares Outstanding (M) 584.49
30 Day Average Volume 1,115,584
Price/Book (mrq) 7.9871
Price/Sale (ttm) 7.6340
Dividend Indicated Gross Yield 0.68%
Cash Dividend (HKD) 0.0660
Dividend Ex-Date 05/15/2015
5 Year Dividend Growth 31.12%
Next Earnings Announcement 11/16/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 950

  • Revenue
  • Net Income (M/HKD)
  • Profit Margin (%)

Company Profile & Key Executives for 950

Lee's Pharmaceutical Holdings Limited develops, manufactures and sells quality biopharmaceutical products that focus on combating cardiovascular diseases and viral sexually transmitted diseases.

Lee Siu FongChairmanLi XiaoyiCEO/CTO/Founder
Chow Yiu MingCFO/SecretaryLeelalertsuphakun WaneeChief Mktg & Sales Officer
More Company Profile & Key Executives for 950

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil